Use of anti-CD3/CD28 mAb coupled magnetic beads permitting subsequent phenotypic analysis of activated human T cells by indirect immunofluorescencePENE, Jérome; RAHMOUN, Massilva; TEMMERMAN, Stéphane et al.Journal of immunological methods. 2003, Vol 283, Num 1-2, pp 59-66, issn 0022-1759, 8 p.Article

Immunosuppressive properties of anti-CD3 single-chain Fv and diabodyLE GALL, Fabrice; REUSCH, Uwe; MOLDENHAUER, Gerhard et al.Journal of immunological methods. 2004, Vol 285, Num 1, pp 111-127, issn 0022-1759, 17 p.Article

Inhibition of anti-CD3 and interleukin-2 stimulated T lymphocyte proliferation by peptidomimetic opioid compoundNARAYAN, P; PANDEY, R; YADAV, V. S et al.Immunopharmacology and immunotoxicology. 2003, Vol 25, Num 2, pp 225-233, issn 0892-3973, 9 p.Article

Case 6: Benefits and risks of OKT3 treatment in renal transplantationROY FIRST, M; MD.Transplantation. 2001, Vol 72, Num 6, pp 1177-1178, issn 0041-1337Article

Interleukin-2 fusion protein with anti-CD3 single-chain Fv (sFv) selectively protects T cells from dexamethasone-induced apoptosisKIM, Eui J; CHO, Daeho; HWANG, Seung Y et al.Vaccine. 2001, Vol 20, Num 3-4, pp 608-615, issn 0264-410XArticle

Anti-CD3 priming generates heterogeneous antigen-specific memory CD4 T cellsPATKE, Deepa S; AHMADZADEH, Mojgan; BINGAMAN, Adam W et al.Clinical immunology (Orlando, Fla. Print). 2005, Vol 117, Num 2, pp 125-132, issn 1521-6616, 8 p.Article

Induction of Active Tolerance and Involvement of CD1d-Restricted Natural Killer T Cells in Anti-CD3 F(ab')₂ Treatment-Reversed New-Onset Diabetes in Nonobese Diabetic MiceGUOJIANG CHEN; GENCHENG HAN; JIANAN WANG et al.The American journal of pathology. 2008, Vol 172, Num 4, pp 972-979, issn 0002-9440, 8 p.Article

Overexpression of an anti-CD3 immunotoxin increases expression and secretion of molecular chaperone BiP/Kar2p by Pichia pastorisYUAN YI LIU; JUNE HEE WOO; NEVILLE, David M et al.Applied and environmental microbiology (Print). 2005, Vol 71, Num 9, pp 5332-5340, issn 0099-2240, 9 p.Article

Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of β-cellsSHERRY, Nicole A; WEI CHEN; KUSHNER, Jake A et al.Endocrinology (Philadelphia). 2007, Vol 148, Num 11, pp 5136-5144, issn 0013-7227, 9 p.Article

Anaphylactoid reaction to muromonab-CD3 in a pediatric renal transplant recipientBERKOWITZ, R. J; POSSIDENTE, C. J; MCPHERSON, B. R et al.Pharmacotherapy. 2000, Vol 20, Num 1, pp 100-104, issn 0277-0008Article

The fate of renal allografts treated with OKT3 for steroid-resistant rejectionVERONESE, F. V; GONCALVES, L. F; VILARINHO, L. L et al.Transplantation proceedings. 1999, Vol 31, Num 7, pp 3016-3018, issn 0041-1345Conference Paper

Construction and characterization of a novel fusion protein consisting of anti-CD3 antibody fused to recombinant interleukin-2LEE, Kuan-Der; CHEN, Hsin-Wei; CHEN, Chih-Cheng et al.Oncology reports. 2006, Vol 15, Num 5, pp 1211-1216, issn 1021-335X, 6 p.Article

Induction immunosuppression in kidney transplant recipients older than 60 years of age: Safety and efficacy of ATGAM®, OKT3® and Simulect®HEIFETS, Michael; SAEED, Muhammad I; PARIKH, Mitten H et al.Drugs & aging. 2004, Vol 21, Num 11, pp 747-756, issn 1170-229X, 10 p.Article

Validation of the COSTIM bioassay for dendritic cell potencySHANKAR, Gopi; FOURRIER, Marc S; GREVENKAMP, Michael A et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 36, Num 2, pp 285-294, issn 0731-7085, 10 p.Article

Impact of OKT3 treatment for steroid resistant rejection of renal allografts : The long-term outcome at a single centerINUI, M; TANABE, K; FUCHINOUE, S et al.Transplantation proceedings. 1999, Vol 31, Num 7, pp 2870-2871, issn 0041-1345Conference Paper

Tolérance de l'OKT3 = Tolerance of OKT3LEBERT, C; POSTIC, C; HAMON, L et al.Journal de pharmacie clinique (Paris). 1997, Vol 16, Num 2, pp 97-103, issn 0291-1981Article

Immunosuppressive agents in clinical trials in transplantationHALLORAN, P. F.The American journal of the medical sciences. 1997, Vol 313, Num 5, pp 283-288, issn 0002-9629Article

Natural Killer Cells Modulate Overt Autoimmunity to Homeostasis in Nonobese Diabetic Mice after Anti-CD3 F(ab')₂ Antibody Treatment through Secreting Transforming Growth Factor-βGUOJIANG CHEN; GENCHENG HAN; JIANAN WANG et al.The American journal of pathology. 2009, Vol 175, Num 3, pp 1086-1094, issn 0002-9440, 9 p.Article

Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4⁺ T cellsLIN, S.-J; CHENG, P.-J; HSIAO, S.-S et al.Bone marrow transplantation (Basingstoke). 2006, Vol 37, Num 9, pp 881-887, issn 0268-3369, 7 p.Article

Comparative study of muromonab-CD3 (OKT3) versus daclizumab (Zenapax) in cardiac transplantation at our centerCAMPOS, A; LAGE, E; HINOJOSA, R et al.Transplantation proceedings. 2005, Vol 37, Num 3, pp 1548-1549, issn 0041-1345, 2 p.Conference Paper

Optimization of human T-cell expansion ex vivo using magnetic beads conjugated with anti-CD3 and anti-CD28 antibodiesKALAMASZ, Dale; LONG, S. A; TANIGUCHI, Ruth et al.Journal of immunotherapy (1997). 2004, Vol 27, Num 5, pp 405-418, issn 1524-9557, 14 p.Article

Transcript profiling of T lymphocytes and dendritic cells in a co-culture system using anti-CD3 and allergen activationGILDEA, Lucy A; RYAN, Cindy A; HULETTE, Ben C et al.Journal of toxicology. Cutaneous and ocular toxicology. 2004, Vol 23, Num 4, pp 277-292, issn 0731-3829, 16 p.Article

Reversible sensorineural hearing loss following administration of muromonab-CD3 (OKT3) for cadaveric renal transplant immunosuppressionHARTNICK, C. J; SMITH, R. V; GREENSTEIN, S et al.The Annals of otology, rhinology & laryngology. 2000, Vol 109, Num 1, pp 45-47, issn 0003-4894Article

Generalized seizures associated with the use of muromonab-CDV in two patients after kidney transplantationSEIFELDIN, R. A; LAWRENCE, K. R; RAHAMTULLA, A. F et al.The Annals of pharmacotherapy. 1997, Vol 31, Num 5, pp 586-589, issn 1060-0280Article

Reversible sensorineural hearing loss after renal transplant immunosuppression with OKT3 (Muromonab-CD3)COHEN, A. F; HARTNICK, C. J; SMITH, R. V et al.The Annals of otology, rhinology & laryngology. 1997, Vol 106, Num 8, pp 640-642, issn 0003-4894Article